Recent data from the Pediatric Cancer Genome Project show that Nur77 is deleted in many hypodiploid acute lymphoblastic leukemia tumors, whereas it is amplified in some patients with Group 4 medulloblastoma (MB) and rhabdomyosarcoma [34]. This evidence concerns the gene NR4A1 and rhabdomyosarcoma.